Smartwatches and coaching aim to prevent heart disease in 1,400 overweight adults
NCT ID NCT07372729
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a smartwatch-based program, combined with coaching from healthcare staff, can improve heart health in overweight or obese adults who have early signs of problems like high blood pressure or prediabetes. The program focuses on exercise and diet, and tracks progress using a smartwatch. Researchers will measure changes in a heart health score called Life's Essential 8 over 6 to 12 months. 1,400 participants are being recruited.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
smartwatch-based behavioral intervention (exercise and diet coaching)
What this could lead to
If it works, this could show that wearable tech and lifestyle coaching can prevent heart disease in people at risk.
What could go wrong
This is a behavioral study, not a drug trial. Results depend on people following the program, and the effect may be small or hard to maintain long-term.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREDIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Chao Yang Hospital
RECRUITINGBeijing, Beijing Municipality, 100013, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Cangzhou Central Hospital
RECRUITINGCangzhou, Hebei, 061012, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Health Community Group of Yuhuan People's Hosptial
RECRUITINGYuhuan, Zhejiang, 317608, China
Contact Phone: •••-•••-•••• Email: •••••@•••••